Published in
Springer, Cancer Immunology, Immunotherapy, 9(68), p. 1417-1428, 2019
DOI: 10.1007/s00262-019-02377-x
Links
Tools
Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone
Journal article published in 2019 by
David Rafei-Shamsabadi 
,
Saskia Lehr,
Dagmar von Bubnoff,
Frank Meiss
,
Saskia Lehr,
Dagmar von Bubnoff,
Frank Meiss
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 